These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21930634)

  • 1. Vancomycin clearance in overweight and obese patients.
    Nix DE; Matthias KR; Erstad BL
    Am J Health Syst Pharm; 2011 Oct; 68(19):1776-7; author reply 1777-8. PubMed ID: 21930634
    [No Abstract]   [Full Text] [Related]  

  • 2. Determining vancomycin clearance in an overweight and obese population.
    Leong JV; Boro MS; Winter M
    Am J Health Syst Pharm; 2011 Apr; 68(7):599-603. PubMed ID: 21411801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing two predictive methods for determining serum vancomycin concentrations at a Veterans Affairs Medical Center.
    Lee E; Winter ME; Boro MS
    Am J Health Syst Pharm; 2006 Oct; 63(19):1872-5. PubMed ID: 16990634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin trough concentrations in overweight or obese pediatric patients.
    Heble DE; McPherson C; Nelson MP; Hunstad DA
    Pharmacotherapy; 2013 Dec; 33(12):1273-7. PubMed ID: 23798327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers.
    Nelson WK; Formica RN; Cooper DL; Schwartz PE; Rutherford TJ
    J Oncol Pharm Pract; 2012 Sep; 18(3):323-32. PubMed ID: 22331238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin dosage in overweight and obese children.
    Miller M; Miller JL; Hagemann TM; Harrison D; Chavez-Bueno S; Johnson PN
    Am J Health Syst Pharm; 2011 Nov; 68(21):2062-8. PubMed ID: 22011985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychotics.
    Lin CC; Bai YM; Wang YC; Chen TT; Lai IC; Chen JY; Chen SY; Gau SS; Liou YJ
    J Clin Psychopharmacol; 2009 Dec; 29(6):529-36. PubMed ID: 19910716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents.
    van Rongen A; Vaughns JD; Moorthy GS; Barrett JS; Knibbe CA; van den Anker JN
    Br J Clin Pharmacol; 2015 Nov; 80(5):1185-96. PubMed ID: 26044579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin dosing in obese pediatric patients.
    Moffett BS; Kim S; Edwards MS
    Clin Pediatr (Phila); 2011 May; 50(5):442-6. PubMed ID: 21282257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exenatide in obese or overweight patients without diabetes: A systematic review and meta-analyses of randomized controlled trials.
    Su N; Li Y; Xu T; Li L; Kwong JS; Du H; Ren K; Li Q; Li J; Sun X; Li S; Tian H
    Int J Cardiol; 2016 Sep; 219():293-300. PubMed ID: 27343423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing.
    Natale S; Bradley J; Nguyen WH; Tran T; Ny P; La K; Vivian E; Le J
    Pharmacotherapy; 2017 Mar; 37(3):361-378. PubMed ID: 28079262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans.
    Prabaker KK; Tran TP; Pratummas T; Goetz MB; Graber CJ
    J Hosp Med; 2012 Feb; 7(2):91-7. PubMed ID: 22086511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of initial dofetilide dosing recommendation based on actual body weight in overweight and obese patients.
    Cao DX; Kohatsu A; Eng L; Mei K; Dinh J; Mok I; Moreau N; Le A; Shin J
    J Clin Pharm Ther; 2015 Dec; 40(6):635-9. PubMed ID: 26365492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity prevalence among veterans at Veterans Affairs medical facilities.
    Das SR; Kinsinger LS; Yancy WS; Wang A; Ciesco E; Burdick M; Yevich SJ
    Am J Prev Med; 2005 Apr; 28(3):291-4. PubMed ID: 15766618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial factors associated with binge eating among overweight and obese male veterans.
    Rosenberger PH; Dorflinger L
    Eat Behav; 2013 Aug; 14(3):401-4. PubMed ID: 23910790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of care among obese patients.
    Chang VW; Asch DA; Werner RM
    JAMA; 2010 Apr; 303(13):1274-81. PubMed ID: 20371786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Documentation of weight management practices for individuals with spinal cord injuries and disorders.
    Locatelli SM; LaVela SL
    Spinal Cord; 2016 Dec; 54(12):1176-1182. PubMed ID: 27163450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption in the Relationship between Blood Pressure and Salty Taste Thresholds among Overweight and Obese Children.
    Bobowski NK; Mennella JA
    J Acad Nutr Diet; 2015 Aug; 115(8):1272-82. PubMed ID: 25843808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body fat changes and activity of tumor necrosis factor α system--a 5-year follow-up study.
    Olszanecka-Glinianowicz M; Chudek J; Kocełak P; Szromek A; Zahorska-Markiewicz B
    Metabolism; 2011 Apr; 60(4):531-6. PubMed ID: 20580040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.